Circulating tumor cells in cancer-risk populations as a cancer interception tool | ||
| dc.conicet.organizacion | GENYO Centre for Genomics and Oncological Research | |
| dc.conicet.organizacion | Hospital Virgen de Las Nieves | |
| dc.conicet.organizacion | IBS Granada | |
| dc.conicet.organizacion | Icahn School of Medicine at Mount Sinai | |
| dc.conicet.organizacion | GENYO Centre for Genomics and Oncological Research | |
| dc.conicet.organizacion | Hospital Virgen de Las Nieves | |
| dc.conicet.organizacion | IBS Granada | |
| dc.conicet.organizacion | IBS Granada | |
| dc.conicet.organizacion | Hospital Virgen de Las Nieves | |
| dc.conicet.organizacion | Universidad de Granada | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | GENYO Centre for Genomics and Oncological Research | |
| dc.conicet.organizacion | Universidad de Buenos Aires | |
| dc.contributor.author | Serrano, Maria Jose | |
| dc.contributor.author | Christian, Rolfo | |
| dc.contributor.author | Expósito Hernandez, José | |
| dc.contributor.author | Garrido Navas, Carmen | |
| dc.contributor.author | Lopez Hidalgo, Javier | |
| dc.contributor.author | Denninghoff, Valeria Cecilia | |
| dc.date.issued | 2023-05 | |
| dc.description.abstract | Cancer interception (CI) is a new approach to cancer prevention and treatment in a cancer-risk population that aims to detect and treat pre-tumoral stages. It has several potential advantages over traditional cancer diagnosis and monitoring methods because it is non-invasive, making it less painful and risky than conventional biopsy procedures. The circulating tumor cells (CTCs), liquid biopsy family members, are essential for the CI approach; then, the liquid biopsy (LB) is used as a CI tool. LB can be performed frequently because of its easy sampling and early pathological stages, which allow repeated non-invasive monitoring of cancer progression and response to treatment. CTCs have been found in the bloodstream of several types of cancer patients, including in early-stage cancer and premalignant lesions, suggesting a tumor development role in cancer's early stages. This chapter will present foundational scientific studies addressing CI and the clinical impact of CTC screening in a population at risk for cancer. | es |
| dc.description.fil | Fil: Serrano, Maria Jose. GENYO Centre for Genomics and Oncological Research; España. Hospital Virgen de Las Nieves; España. IBS Granada; España | |
| dc.description.fil | Fil: Christian, Rolfo. Icahn School of Medicine at Mount Sinai; Estados Unidos | |
| dc.description.fil | Fil: Expósito Hernandez, José. GENYO Centre for Genomics and Oncological Research; España. Hospital Virgen de Las Nieves; España. IBS Granada; España | |
| dc.description.fil | Fil: Garrido Navas, Carmen. IBS Granada; España. Hospital Virgen de Las Nieves; España | |
| dc.description.fil | Fil: Lopez Hidalgo, Javier. Universidad de Granada; España | |
| dc.description.fil | Fil: Denninghoff, Valeria Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. GENYO Centre for Genomics and Oncological Research; España. Universidad de Buenos Aires; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Serrano, Maria Jose; Christian, Rolfo; Expósito Hernandez, José; Garrido Navas, Carmen; Lopez Hidalgo, Javier; et al.; Circulating tumor cells in cancer-risk populations as a cancer interception tool; Elsevier; International Review of Cell and Molecular Biology; 381; 5-2023; 113-129 | es |
| dc.identifier.eissn | 1937-6448 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/236250 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.pagination | 113-129 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | International Review of Cell and Molecular Biology | es |
| dc.journal.volume | 381 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/bs.ircmb.2023.07.001 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S1937644823001156 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | Circulating tumor cells | es |
| dc.subject | Cancer interception | es |
| dc.subject | Liquid biopsy | es |
| dc.subject | Risk population | es |
| dc.subject.classification | Oncología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Circulating tumor cells in cancer-risk populations as a cancer interception tool | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b473baa4-ed5b-4204-9aca-963ad0b6b678_B.pdf
- Tamaño:
- 1.16 MB
- Formato:
- Adobe Portable Document Format